28 research outputs found

    Saturated Fatty Acids Modulate Autophagy's Proteins In The Hypothalamus

    Get PDF
    Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Autophagy is an important process that regulates cellular homeostasis by degrading dysfunctional proteins, organelles and lipids. In this study, the hypothesis that obesity could lead to impairment in hypothalamic autophagy in mice was evaluated by examining the hypothalamic distribution and content of autophagic proteins in animal with obesity induced by 8 or 16 weeks high fat diet to induce obesity and in response to intracerebroventricular injections of palmitic acid. The results showed that chronic exposure to a high fat diet leads to an increased expression of inflammatory markers and downregulation of autophagic proteins. In obese mice, autophagic induction leads to the downregulation of proteins, such as JNK and Bax, which are involved in the stress pathways. In neuron cell-line, palmitate has a direct effect on autophagy even without inflammatory activity. Understanding the cellular and molecular bases of overnutrition is essential for identifying new diagnostic and therapeutic targets for obesity.103Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)FAPESP [2011/14565-4, RA 2011/51205-6

    Defective apoptosis in intestinal and mesenteric adipose tissue of crohn's disease patients

    Get PDF
    Background: Crohn's disease (CD) is associated with complex pathogenic pathways involving defects in apoptosis mechanisms. Recently, mesenteric adipose tissue (MAT) has been associated with CD ethiopathology, since adipose thickening is detected close to the affected intestinal area. However, the potential role of altered apoptosis in MAT of CD has not been addressed. Aims: To evaluate apoptosis in the intestinal mucosa and MAT of patients with CD. Methods: Samples of intestinal mucosa and MAT from patients with ileocecal CD and from non-inflammatory bowel diseases patients (controls) were studied. Apoptosis was assessed by TUNEL assay and correlated with the adipocytes histological morphometric analysis. The transcriptional and protein analysis of selected genes and proteins related to apoptosis were determined. Results: TUNEL assay showed fewer apoptotic cells in CD, when compared to the control groups, both in the intestinal mucosa and in MAT. In addition, the number of apoptotic cells (TUNEL) correlated significantly with the area and perimeter of the adipose cells in MAT. Transcriptomic and proteomic analysis reveal a significantly lower transcript and protein levels of Bax in the intestinal mucosa of CD, compared to the controls; low protein levels of Bax were found localized in the lamina propria and not in the epithelium of this tissue. Furthermore, higher level of Bcl-2 and low level of Caspase 3 were seen in the MAT of CD patients. Conclusion: The defective apoptosis in MAT may explain the singular morphological characteristics of this tissue in CD, which may be implicated in the pathophysiology of the disease. © 2014 Dias et al.Crohn's disease (CD) is associated with complex pathogenic pathways involving defects in apoptosis mechanisms. Recently, mesenteric adipose tissue (MAT) has been associated with CD ethiopathology, since adipose thickening is detected close to the affected intestinal area. However, the potential role of altered apoptosis in MAT of CD has not been addressed. Aims: To evaluate apoptosis in the intestinal mucosa and MAT of patients with CD. Methods: Samples of intestinal mucosa and MAT from patients with ileocecal CD and from non-inflammatory bowel diseases patients (controls) were studied. Apoptosis was assessed by TUNEL assay and correlated with the adipocytes histological morphometric analysis. The transcriptional and protein analysis of selected genes and proteins related to apoptosis were determined. Results: TUNEL assay showed fewer apoptotic cells in CD, when compared to the control groups, both in the intestinal mucosa and in MAT. In addition, the number of apoptotic cells (TUNEL) correlated significantly with the area and perimeter of the adipose cells in MAT. Transcriptomic and proteomic analysis reveal a significantly lower transcript and protein levels of Bax in the intestinal mucosa of CD, compared to the controls; low protein levels of Bax were found localized in the lamina propria and not in the epithelium of this tissue. Furthermore, higher level of Bcl-2 and low level of Caspase 3 were seen in the MAT of CD patients. Conclusion: The defective apoptosis in MAT may explain the singular morphological characteristics of this tissue in CD, which may be implicated in the pathophysiology of the disease96e9854

    Toll-like Receptor 4, F4/80 And Pro-inflammatory Cytokines In Intestinal And Mesenteric Fat Tissue Of Crohn's Disease.

    Get PDF
    Crohn's disease (CD) is a chronic intestinal ailment with a multifactorial etiology, whose incidence has increased during the last three decades. Recently, a role for mesenteric fat has been proposed in CD pathophysiology, since fat hypertrophy is detected nearby the affected intestinal area; however, there are few studies on this aspect. To evaluate inflammatory activity in intestinal mucosa and mesenteric fat tissue of patients with CD and controls. Ten patients with ileocecal CD and 16 patients with non-inflammatory disease (control groups) were studied. The specimens were snap-frozen and the expression of TLR-4, F4/80, IL1-β and IL-6 were determined by immunoblot of protein extracts. TLR4 RNA level were measured using RT-PCR. The t Test was applied (p<0.05). The local ethical committee approved the study. The intestinal mucosa of CD group had significantly higher protein levels of TLR-4, F4/80, IL-1β and IL-6 than the controls. The gene expression of TLR4 was lower in the intestinal mucosa of CD compared to the control group. Regard the mesenteric fat tissue, there was no statistical difference related to TLR-4, F4/80, IL-1β and IL-6 proteins expression. These findings may result from an up-regulation of macrophage activation and intracellular pathways activated by bacterial antigens, which are more important in intestinal mucosa than fat tissue in CD patients. This may represent an anomalous regulation of innate immunity and could contribute to the production of proinflammatory mediators and disease development.698-10

    Autophagy And Proinfl Ammatory Cytokine Expression In The Intestinal Mucosa And Mesenteric Fat Tissue Of Patients With Crohn's Disease [autofagia E Expressão De Citocinas Pró-infl Amatórias Na Mucosa Intestinal E No Tecido Mesenterial De Pacientes Com Doença De Crohn]

    No full text
    Background: Recently, mesenteric fat has been proposed to play a role in the pathophysiology of Crohn's disease (CD), as fat hypertrophy is detected close to the affected intestinal area; however, there are few studies regarding autophagy and creeping fat tissue in CD. Objective: Evaluate autophagy-related proteins and proinfl ammatory cytokines in intestinal mucosa and mesenteric fat in patients with CD and controls. Patients and methods: Ten patients with CD, eight with non-infl ammatory disease who underwent surgery, and eight with normal ileocolonoscopy were studied. The expression of LC3-II, TNF-α and IL-23 was determined by immunoblot of protein extracts. In addition, total RNA of LC3 and Atg16-L1 were determined using RT-PCR. Results: The expression of LC3-II was signifi cantly lower in the mesenteric tissue of CD when compared to controls (p < 0.05). In contrast, the intestinal mucosa of the CD group had higher levels of LC3-II (p < 0.05). However, mRNA expression of autophagy-related proteins was similar when compared to mesenteric fat groups. TNF-α and IL-23 expressions were higher in intestinal mucosa of CD than in control (p < 0.05). Conclusion: These fi ndings suggest a defect in the autophagic activity of the creeping fat tissue in CD, which could be involved with the maintenance of the infl ammatory process in the intestinal mucosa. © 2013 Elsevier Editora Ltda. All rights reserved.331915Heatha, R.J., Xavier, R.J., Autophagy immunity and human disease (2009) Curr Opin Gastroenterol, 25, pp. 512-520Cummings, J.R., Cooney, R., Pathan, S., Anderson, C.A., Barrett, J.C., Beckly, J., Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene (2007) Infl Amm Bowel Dis, 13, pp. 941-946Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., A genome-wide association scan of nonsynonymous SNPs identifi es a susceptibility variant for Crohn's disease in ATG16L 1 (2007) Nat Genet, 39, pp. 207-211Parkes, M., Barrett, J.C., Prescott, N.J., Tremelling, M., Anderson, C.A., Fisher, S.A., Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility (2007) Nat Genet, 39, pp. 830-832Eskelinen, E.L., Maturation of autophagic vacuoles in Mammalian cells (2005) Autophagy, 1, pp. 1-10Lum, J.J., Bauer, D.E., Kong, M., Harris, M.H., Li, C., Lindsten, T., Growth Factor Regulation of Autophagy and Cell Survival In the Absence of Apoptosis (2005) Cell, 120, pp. 237-248Abedin, M.J., Wang, D., McDonnell, M.A., Lehmann, U., Kelekar, A., Autophagy delays apoptotic death in breast cancer cells following DNA damage (2007) Cell Death Differ, 14, pp. 500-510Colell, A., Ricci, J.E., Tait, S., Milasta, S., Maurer, U., Bouchier-Hayes, L., GAPDH and Autophagy Preserve Survival After Apoptotic Cytochrome Crelease In the Absence of Caspase Activation (2007) Cell, 129, pp. 983-997Tanida, I., Autophagosome formation and molecular mechanism of autophagy (2011) Antioxid Redox Signal, 14, pp. 2201-2214Weersma, R.K., Stokkers, P.C.F., Vanbodegraven, A.A., Vanhogezand, R.A., Verspaget, H.W., Dejong, D.J., Molecular Prediction of Disease Risk and Severity In a Large Dutch Crohn's Disease Cohort (2009) Gut, 58 (3), pp. 388-395Golder, W.A., The "creeping fat sign"-really diagnostic for Crohn's disease? (2009) Int J Colorectal Dis, 24 (1), pp. 1-4Bertina, B., Desreumauxa, P., Dubuquoy, L., Obesity, visceral fat and Crohn's disease (2010) Curr Op Clin Nutr Metab Care, 13, pp. 574-580Sheehan, A.L., Warren, B.F., Gear, M.W., Shepherd, N.A., Fat-wrapping in Crohn's disease. pathological basis and relevance to surgical practice (1992) Br J Surg, 79, pp. 955-958Olivier, I., Théodorou, V., Valet, P., Castan-Laurell, I., Guillou, H., Bertrand-Michel, J., Is Crohn's creeping fat an adipose tissue? (2011) Infl Amm Bowel Dis, 17 (3), pp. 747-757Vettor, R., Milan, G., Rossato, M., Federspil, G., Review article: Adipocytokines and insulin resistance (2005) Aliment Pharmacol Ther, 22 (2), pp. 3-10Lin, Y., Lee, H., Berg, A.H., Lisanti, M.P., Shapiro, L., Scherer, P.E., The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes (2000) J Biol Chem, 275, pp. 24255-24263Batra, A., Pietsch, J., Stroh, T., Fedke, I., Glauben, R., Okur, B., Tolllike receptor expression and response to specifi c stimulation in adipocytes and preadipocytes: On the role of fat in infl ammation (2006) Ann N Y Acad Sci, 1072, pp. 407-409Gay, J., Tachon, M., Neut, C., Mesenteric adipose tissue is colonized by bacterial fl ora and express pathogen recognition receptors in Crohn's disease [abstract] (2005) Gastroenterology, 128 (2), pp. A503Dereumaux, P., Ernst, O., Geboes, K., Gambiez, L., Berrebi, D., Müller-Alouf, H., Infl ammatory alterations in mesenteric adipose tissue in Crohn's disease (1999) Gastroenterology, 117, pp. 73-81Barbier, M., Vidal, H., Desreumaux, P., Dubuquoy, L., Bourreille, A., Colombel, J.F., Overexpression of leptin mRNA in mesenteric adipose tissue in infl ammatory bowel diseases (2003) Gastroenterol Clin Biol, 27, pp. 987-991Yamamoto, K., Kiyohara, T., Murayama, Y., Kihara, S., Okamoto, Y., Funahashi, T., Production of Adiponectin, An Antiinfl Ammatory Protein, In Mesenteric Adipose Tissue In Crohn's Disease (2005) Gut, 54, pp. 789-796Peyrin-Biroulet, L., Gonzalez, F., Dubuquoy, L., Rousseaux, C., Dubuquoy, C., Decourcelle, C., Mesenteric Fat As a Source of C Reactive Protein and As a Target For Bacterial Translocation In Crohn's Disease (2012) Gut, 61 (1), pp. 78-85Peyrin-Biroulet, L., Chamaillard, M., Gonzalez, F., Beclin, E., Decourcelle, C., Antunes, L., Mesenteric Fat In Crohn's Disease: A Pathogenetic Hallmark Or An Innocent Bystander? (2007) Gut, 56 (4), pp. 577-583Zulian, A., Cancello, R., Micheletto, G., Gentilini, D., Gilardini, L., Danelli, P., Visceral Adipocytes: Old Actors In Obesity and New Protagonists In Crohn's Disease? (2012) Gut, 61 (1), pp. 86-94Mizushima, N., Yoshimori, T., How to interpret LC3 immunoblotting (2007) Autophagy, 3, pp. 542-545Choi, A.J.S., Ryter, S.W., Autophagy in inflammatory diseases (2011) Int J Cell Biol, 2011, p. 732798Best, W.R., Becktel, J.M., Singleton, J.W., Kern Jr., F., Development of a Crohn's disease activity index. National Cooperative Crohn's disease Study (1976) Gastroenterology, 70 (3), pp. 439-444Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal Biochem, 72, pp. 248-254Araújo, E.P., de Souza, C.T., Gasparetti, A.L., Ueno, M., Boschero, A.C., Saad, M.J., Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistence, hyperinsulinemia, and increased adiposity (2005) Endocrinology, 146, pp. 1428-1437Homer, C.G., Richmond, A.L., Rebert, N.A., Achkar, J.P., McDonald, C., ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis (2010) Gastroenterology, 139, pp. 1630-1641Rioux, J.D., Xavier, R.J., Taylor, K.D., Silverberg, M.S., Goyette, P., Huett, A., Genome-wide association study identifi es new susceptibility loci for Crohn's disease and implicates autophagy in disease pathogenesis (2007) Nat Genet, 39, pp. 596-604Yano, T., Kurata, S., An unexpected twist for autophagy in Crohn's disease (2009) Nat Immunol, 10 (2), pp. 134-136Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing (2000) EMBO J, 19, pp. 5720-5728Martineza, J., Almendingerb, J., Obersta, A., Nessa, R., Dillona, C.P., Fitzgeralda, P., Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the effi cient clearance of dead cells (2011) Proc Natl Acad Sci USA, 108 (42), pp. 17396-17401Mizushima, N., Kuma, A., Kobayashi, Y., Yamamoto, A., Matsubae, M., Takao, T., Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate (2003) J Cell Sci, 116, pp. 1679-1688Hubbard, V.M., Cadwell, K., Viruses, autophagy genes, and Crohn's disease (2011) Viruses, 3, pp. 1211-1281Cheong, H., Nair, U., Geng, J., Klionsky, D.J., The Atg1 kinase complex is involved in the regulation of protein recruitment to initiate sequestering vesicle formation for nonspecifi c autophagy in Saccharomyces cerevisiae (2007) Mol Biol Cell, 19, pp. 668-681Klionsky, D.J., The molecular machinery of autophagy: Unanswered questions (2005) J Cell Sci, 118, pp. 7-18Saitoh, T., Fujita, N., Jang, M.H., Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production (2008) Nature, 456, pp. 264-268Stappenbeck, T.S., Rioux, J.D., Mizoguchi, A., Saitoh, T., Huett, A., Darfeuille-Michaud, A., Crohn disease. A current perspective on genetics, autophagy and immunity (2011) Autophagy, 7 (4), pp. 355-374Santaolalla, R., Abreu, M.T., Innate immunity in the small intestine (2012) Curr Opin Gastroenterol, 28 (2), pp. 124-129Lapaquette, P., Glasser, A.L., Huett, A., Xavier, R.J., Darfeuille-Michaud, A., Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly (2010) Cell Microbiol, 12 (1), pp. 99-113Tsianos, E.V., Katsanos, K.H., Tsianos, V.E., Role of genetics in the diagnosis and prognosis of Crohn's disease (2012) World J Gastroenterol, 18 (2), pp. 105-118Brest, P., Corcelle, E.A., Cesaro, A., Chargui, A., Belaïd, A., Klionsky, D.J., Autophagy and Crohn's disease: At the crossroads of infection, inflammation, immunity, and cancer (2010) Curr Mol Med, 10, pp. 486-502Levine, B., Mizushima, N., Virgin, H.W., Autophagy in immunity and inflammation (2011) Nature, 469, pp. 323-335Cris, T.O., Plantinga, T.S., van de Veerdonk, F.L., Farcas, M.F., Stoffels, M., Kullberg, B.J., Infl ammasome-independent modulation of cytokine response by autophagy in human cells (2011) PLoS One, 6 (4), pp. e18666Garrett, W.S., Gordon, J.I., Glimcher, L.H., Homeostasis and Infl Ammation In the Intestine (2010) Cell, 140, pp. 859-870Cecconi, F., Autophagy regulation by miRNAs: When cleaning goes out of service (2011) EMBO J, 30, pp. 4517-4519Inui, M., Martello, G., Piccolo, S., MicroRNA control of signal transduction (2010) Nat Rev Mol Cell Biol, 11, pp. 252-263Frankel, L.B., Wen, J., Lees, M., Høyer-Hansen, M., Farkas, T., Krogh, A., MicroRNA-101 is a potent inhibitor of autophagy (2011) EMBO J, 30 (22), pp. 4628-4641Brest, P., Lapaquette, P., Souidi, M., Lebrigand, K., Cesaro, A., Vouret-Craviari, V., A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease (2011) Nat Genet, 43 (3), pp. 242-245Xiao, J., Zhu, X., He, B., Zhang, Y., Kang, B., Wang, Z., MiR-204 regulates cardiomyocyte autophagy induced by ischemiareperfusion through LC3-II (2011) J Biomed Sci, 18, p. 35Cadwell, K., Liu, J., Brown, S.L., Miyoshi, H., Loh, J., Lennerz, J., A unique role for autophagy and Atg16L1 in Paneth cells in murine and human intestine (2008) Nature, 13, pp. 259-263. , 456: 7219Crohn, B.B., Ginzburg, L., Openheimer, G.D., Regionalileitis: A clinical and pathological entity (1932) JAMA, 99, pp. 1323-1329Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante Jr., A.W., Obesity is associated with macrophage accumulation in adipose tissue (2003) J Clin Invest, 112, pp. 1796-1808Curat, C.A., Miranville, A., Sengenes, C., Diehl, M., Tonus, C., Busse, R., From blood monocytes to adipose tissue-resident macrophages: Induction of diapedesis by human mature adipocytes (2004) Diabetes, 53, pp. 1285-129

    Autophagy is decreased in mesenteric fat tissue but not in intestinal mucosae of patients with Crohn's disease

    No full text
    Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Crohn's disease (CD) is a chronic intestinal disease with a multifactorial etiology. Recently, a role for mesenteric fat has been proposed in CD pathophysiology, since fat hypertrophy is detected close to the affected intestinal area; however, there are few studies regarding autophagy and the hypertrophied mesenteric tissue in CD. To evaluate autophagy-related proteins in intestinal mucosae and mesenteric fat of patients with CD and controls, patients with ileocecal CD (CD Group) and with non-inflammatory disease (FC Group) selected for surgery were studied. Expression of LC3-II was determined by immunoblotting of protein extracts. In addition, beclin-1, LC3 and Atg16-L1 RNA levels were measured using RT-PCR. The expression of LC3-II was significantly lower in the mesenteric tissue and higher in intestinal mucosae of CD when compared to controls. However, mRNA expression of autophagy-related proteins was similar when comparing the mesenteric fat groups. These findings suggest a defect in autophagy activation in the mesenteric fat tissue of CD individuals, which could be involved in the maintenance of the inflammatory process.3503549552Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP
    corecore